This episode delves into the critical aspect of risk management during the scale-up of pharmaceutical manufacturing processes. We'll explore strategies for identifying and mitigating potential risks. These risks can range from unexpected side reactions and impurity formation to equipment failures and safety hazards.

The conversation centers on proactive risk assessment. This includes techniques like process hazard analysis and failure mode and effects analysis. We'll discuss contingency planning, emphasizing the importance of having backup plans in place to address potential problems. Real-world examples from OPR&D illustrate how manufacturers use these risk management principles to ensure safe and efficient scale-up.